Antoni Wiedlocha funded by the EEA Poland-Norway grants
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Smiseth OA, Fernandes JF, Ohte N, Wakami K, Donal E, Remme EW, Lamata P(2025) Imaging-based method to quantify left ventricular diastolic pressures Eur Heart J Cardiovasc Imaging(in press) DOI 10.1093/ehjci/jeaf017, PubMed 39821267
Staubo SC, Fuskevåg OM, Toft M, Lie IH, Alvik KMJ, Jostad P, Tingvoll SH, Lilleng H, Rosqvist K, Størset E, Odin P, Dietrichs E, Dietrichs ES(2025) Impulse control and correlation to dopamine agonist serum concentrations in people with Parkinson's disease J Neurol, 272(2), 134 DOI 10.1007/s00415-024-12870-8, PubMed 39812843
Martinsen AE, Børte S, Spildrejorde M, Brumpton BM, Heuch I, Zwart JA, Winsvold BS(2025) Insights into Chronic Low Back Pain Etiology: Population-based genome-wide Association Study Identifies 18 Risk Loci Spine (Phila Pa 1976)(in press) DOI 10.1097/BRS.0000000000005254, PubMed 39812312